302 related articles for article (PubMed ID: 11888329)
1. The impact of efflux transporters in the brain on the development of drugs for CNS disorders.
Taylor EM
Clin Pharmacokinet; 2002; 41(2):81-92. PubMed ID: 11888329
[TBL] [Abstract][Full Text] [Related]
2. [Membrane Transporters and Their Regulatory Mechanisms at the Brain and Retinal Barriers to Establish Therapies for Refractory Central Nervous System Diseases].
Akanuma SI
Yakugaku Zasshi; 2020; 140(10):1235-1242. PubMed ID: 32999202
[TBL] [Abstract][Full Text] [Related]
3. Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
[TBL] [Abstract][Full Text] [Related]
4. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
Löscher W; Potschka H
Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
[TBL] [Abstract][Full Text] [Related]
5. Drug efflux transporters in the CNS.
Sun H; Dai H; Shaik N; Elmquist WF
Adv Drug Deliv Rev; 2003 Jan; 55(1):83-105. PubMed ID: 12535575
[TBL] [Abstract][Full Text] [Related]
6. [Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system].
Ohtsuki S
Yakugaku Zasshi; 2004 Nov; 124(11):791-802. PubMed ID: 15516806
[TBL] [Abstract][Full Text] [Related]
7. Transporter-based delivery of anticancer drugs to the brain: improving brain penetration by minimizing drug efflux at the blood-brain barrier.
On NH; Miller DW
Curr Pharm Des; 2014; 20(10):1499-509. PubMed ID: 23789953
[TBL] [Abstract][Full Text] [Related]
8. Transporter-mediated permeation of drugs across the blood-brain barrier.
Tamai I; Tsuji A
J Pharm Sci; 2000 Nov; 89(11):1371-88. PubMed ID: 11015683
[TBL] [Abstract][Full Text] [Related]
9. Neotrofin is transported out of brain by a saturable mechanism: possible involvement of multidrug resistance and monocarboxylic acid transporters.
Yan R; Taylor EM
Drug Metab Dispos; 2002 May; 30(5):513-8. PubMed ID: 11950780
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier drug discovery for central nervous system infections.
Jong A; Huang SH
Curr Drug Targets Infect Disord; 2005 Mar; 5(1):65-72. PubMed ID: 15777199
[TBL] [Abstract][Full Text] [Related]
11. Nature and consequences of mammalian brain and CSF efflux transporters: four decades of progress.
Spector R
J Neurochem; 2010 Jan; 112(1):13-23. PubMed ID: 19860860
[TBL] [Abstract][Full Text] [Related]
12. Involvement of multidrug resistance-associated protein 4 in efflux transport of prostaglandin E(2) across mouse blood-brain barrier and its inhibition by intravenous administration of cephalosporins.
Akanuma S; Hosoya K; Ito S; Tachikawa M; Terasaki T; Ohtsuki S
J Pharmacol Exp Ther; 2010 Jun; 333(3):912-9. PubMed ID: 20194529
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanisms of drug influx and efflux transport at the blood-brain barrier].
Ohtsuki S; Hori S; Terasaki T
Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):55-64. PubMed ID: 12843573
[TBL] [Abstract][Full Text] [Related]
14. The role of multidrug resistance protein (MRP-1) as an active efflux transporter on blood-brain barrier (BBB) permeability.
Lingineni K; Belekar V; Tangadpalliwar SR; Garg P
Mol Divers; 2017 May; 21(2):355-365. PubMed ID: 28050687
[TBL] [Abstract][Full Text] [Related]
15. [Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].
Tachikawa M; Uchida Y; Terasaki T
Brain Nerve; 2013 Feb; 65(2):121-36. PubMed ID: 23399670
[TBL] [Abstract][Full Text] [Related]
16. Physical and Metabolic Integrity of the Blood-Brain Barrier in HIV Infection: A Special Focus on Intercellular Junctions, Influx and Efflux Transporters and Metabolizing Enzymes.
Shawahna R
Curr Drug Metab; 2015; 16(2):105-23. PubMed ID: 26179607
[TBL] [Abstract][Full Text] [Related]
17. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
[TBL] [Abstract][Full Text] [Related]
18. Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport.
Potschka H
Adv Drug Deliv Rev; 2012 Jul; 64(10):943-52. PubMed ID: 22210135
[TBL] [Abstract][Full Text] [Related]
19. Progress in brain penetration evaluation in drug discovery and development.
Liu X; Chen C; Smith BJ
J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of glutathione-conjugate efflux from the brain into blood: Involvement of multiple transporters in the course.
Okamura T; Okada M; Kikuchi T; Wakizaka H; Zhang MR
J Cereb Blood Flow Metab; 2020 Jan; 40(1):116-125. PubMed ID: 30346895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
